Aptevo Therapeutics Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Seattle, WA
APVO chart
What traders are saying about $APVO
Latest postsAptevo Therapeutics Inc. news
- Aptevo Presents New Multispecific Immunotherapy Data at SITC 2026
TipRanks ·
- Form 8K Aptevo Therapeutics Inc For: 9 November By Investing.com
Investing.com Canada ·
- APVO: Aptevo Therapeutics Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits
Quantisnow ·
- Aptevo Presents Preclinical Data at SITC 2026 Showing Potential to Overcome Immune Suppression in Solid Tumors
Yahoo Finance ·
- In lab tests, two experimental molecules helped immune cells kill cancer cells despite tumor defenses.
Stock Titan ·
- Aptevo Therapeutics Inc. (APVO) Seasonal returns chart
Yahoo Finance UK ·
- Aptevo Therapeutics Inc. (APVO) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- Aptevo Achieves Key Clinical Development Objective, Significantly Reducing Infusion-Related Reactions with Mipletamig in Frontline AML
Yahoo Finance ·
- A revised dose was linked to fewer infusion reactions that can disrupt leukemia care.
Stock Titan ·
- APVO: Mipletamig Combination Therapy Leads to 21% Stem Cell Transplantation Rate
Yahoo Finance ·
- Aptevo Reports Mipletamig Combination Therapy Enabled 21% of Frontline AML Patients to Advance to Potentially Curative Stem Cell Transplant
Yahoo Finance ·
- Aptevo to Showcase Multispecific Platform at SITC 2026 Annual Meeting
Yahoo Finance ·
Aptevo Therapeutics Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | – | – | – | $3.1M |
| Net income | -$26.0M | -$24.1M | -$17.4M | $8.0M |
| Diluted EPS | $-87.27 | $-31460.23 | $-2316.83 | $1.57 |
| Total assets (year end) | $27.2M | $15.6M | $24.8M | $34.2M |
| Cash and equivalents (year end) | $21.6M | $8.7M | $16.9M | $22.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Aptevo Therapeutics Inc.
- Ticker
- APVO (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Seattle, WA
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1671584
Frequently asked questions
What exchange is Aptevo Therapeutics Inc. listed on?
Aptevo Therapeutics Inc. trades on the Nasdaq under the ticker symbol APVO.
What industry is Aptevo Therapeutics Inc. in?
Aptevo Therapeutics Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Aptevo Therapeutics Inc. headquartered?
Aptevo Therapeutics Inc.'s business address on file with the SEC is in Seattle, WA.
When does Aptevo Therapeutics Inc.'s fiscal year end?
Aptevo Therapeutics Inc.'s fiscal year ends on December 31.
How much revenue did Aptevo Therapeutics Inc. report?
Aptevo Therapeutics Inc. reported $3.1M in revenue for calendar year 2022, according to its SEC filings.